On October 25, 2017 DXC Technology (NYSE: DXC), the world’s leading independent, end-to-end IT services company, reported that it will release financial results for the second quarter of fiscal year 2018 on Tuesday, Nov. 7, 2017 at approximately 4:15 p.m. Eastern Standard Time (EST) (Press release, DynPort Vaccine Company, OCT 25, 2017, View Source [SID1234521170]).

DXC Technology senior management will host a conference call and webcast on the same day at 5 p.m. EST. The dial-in number for domestic callers is (800) 289-0438. Callers who reside outside of the United States should dial +1 (323) 794-2423. The passcode for all participants is 1280312. Presentation slides will be available on DXC Technology’s Investor Relations website.

A replay of the conference call will be available from approximately two hours after the conclusion of the call until November 14, 2017. Replay numbers can be found at the following link. The replay passcode is also 1280312.

On October 25, 2017 Juno Therapeutics, Inc. (NASDAQ: JUNO) reported that it will announce financial results for the third quarter 2017 on Wednesday, November 1, 2017, after the close of U.S.-based financial markets (Press release, Juno, OCT 25, 2017, View Source [SID1234521171]). Following the announcement, Juno management will host a conference call and live webcast to provide a business update and discuss financial results beginning at 1:30 p.m. Pacific Time (PT) / 4:30 p.m. Eastern Time (ET).

Analysts and investors can participate in the conference call by dialing (855) 780-7198 for domestic callers and (631) 485-4870 for international callers, using the conference ID# 2899809.
The webcast can be accessed live on the Investor Relations page of Juno’s website, www.JunoTherapeutics.com, and will be available for replay for 30 days following the call.

On October 25, 2017 PDL BioPharma, Inc. (PDL or the Company) (NASDAQ: PDLI) reported that the Company will release its third quarter financial results for the period ended September 30, 2017, on Thursday, November 2, 2017, after market close (Press release, PDL BioPharma, OCT 25, 2017, View Source [SID1234521173]). PDL’s management will host a conference call and webcast that day at 4:30 p.m. Eastern Time to discuss the financial results. A slide presentation relating to the call will be available via the webcast link on the PDL website.

Conference Call Details
To access the live conference call via phone, please dial (800) 668-4132 from the United States and Canada or (224) 357-2196 internationally. The conference ID is 8794857. Please dial in approximately 10 minutes prior to the start of the call. A telephone replay will be available for one week following the call and may be accessed by dialing (855) 859-2056 from the United States and Canada or (404) 537-3406 internationally. The replay passcode is 8794857.

To access the live and subsequently archived webcast of the conference call, go to the Company’s website at View Source and go to “Events & Presentations.” Please connect to the website at least 15 minutes prior to the call to allow for any software download that may be necessary.

On October 25, 2017 Vericel Corporation (NASDAQ:VCEL), a leading developer of autologous expanded cell therapies for the treatment of patients with serious diseases and conditions, reported the following webcast and conference call (Press release, Vericel, OCT 25, 2017, View Source [SID1234521174]):

What: Vericel Corporation Third-Quarter 2017 Earnings Call

When: Tuesday, November 7, 2017 at 8:00am (EST)

Where: View Source

How: The conference call will be available live in the Investors section of the Vericel website
at View Source. Please access the site at least 15 minutes prior
to the scheduled start time in order to download the required audio software if necessary.
To participate in the live call by telephone, please call (877) 312-5881 and reference Vericel Corporation third-quarter 2017 investor conference call. If calling from outside the U.S., please use the international phone number (253) 237-1173.

If you are unable to participate in the live call, the webcast will be available at View Source until November 7, 2018. A replay of the call will also be available until 11:00am (EST) on November 11, 2017 by calling (855) 859-2056, or from outside the U.S. (404) 537-3406. The conference ID is 7097908.

On October 25, 2017 Synthetic Biologics, Inc. (NYSE American: SYN), a late-stage clinical company developing therapeutics that preserve the microbiome to protect and restore the health of patients, announced reported that the Company intends to release its operational highlights and financial results for the quarter ended September 30, 2017 on Wednesday, November 1, 2017, and to host a conference call the same day at 4:30 p.m. EDT(Press release, Synthetic Biologics, OCT 25, 2017, View Source [SID1234521177]). The dial-in information for the call is as follows:

U.S. (toll free): 1-888-347-5280
International: +1 412-902-4280

Participants are asked to dial in 15 minutes before the start of the call to register. The call will also be webcast over the Internet at View Source." target="_blank" title="View Source." rel="nofollow">View Source An archived replay of the call will be available for approximately ninety (90) days at the same URL, View Source, beginning approximately one hour after the call’s conclusion.